Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Healius Limited (HLS) vs. Competitors

69 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
AU:HLSHealius LimitedAUD 0.58AUD 421.18M-1.04-34.09%HoldUnlock the AU:HLS analyst price target with TipRanks PremiumAU:HLSUnlock the AU:HLS top-analyst price target with TipRanks Premium
AU:LDXLumos Diagnostics Holdings Ltd.AUD 0.07AUD 75.10M-7.50-58.86%Moderate BuyUnlock the AU:LDX analyst price target with TipRanks PremiumAU:HLS vs AU:LDXUnlock the AU:LDX top-analyst price target with TipRanks Premium
AU:SHLSonic Healthcare LimitedAUD 20.07AUD 9.92B16.67-3.93%HoldUnlock the AU:SHL analyst price target with TipRanks PremiumAU:HLS vs AU:SHLUnlock the AU:SHL top-analyst price target with TipRanks Premium
AU:IDXIntegral Diagnostics Ltd.AUD 1.63AUD 606.91M27.85-35.52%Moderate BuyUnlock the AU:IDX analyst price target with TipRanks PremiumAU:HLS vs AU:IDXUnlock the AU:IDX top-analyst price target with TipRanks Premium
AU:ACLAustralian Clinical Labs LtdAUD 3.33AUD 621.11M26.9828.08%HoldUnlock the AU:ACL analyst price target with TipRanks PremiumAU:HLS vs AU:ACLUnlock the AU:ACL top-analyst price target with TipRanks Premium
AU:MVFMonash IVF Group LtdAUD 0.74AUD 288.33M39.5325.42%Moderate BuyUnlock the AU:MVF analyst price target with TipRanks PremiumAU:HLS vs AU:MVFUnlock the AU:MVF top-analyst price target with TipRanks Premium

Performance Comparison

-100%-50%0%50%100%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
AU:HLSHealius Limited0.58-0.30-34.09%
AU:LDXLumos Diagnostics Holdings Ltd.0.07-0.10-57.65%
AU:SHLSonic Healthcare Limited20.07-0.33-1.64%
AU:IDXIntegral Diagnostics Ltd.1.63-0.81-33.40%
AU:ACLAustralian Clinical Labs Ltd3.330.8132.30%
AU:MVFMonash IVF Group Ltd0.740.1730.05%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts